Quotient Sciences – UK Headquarters – Nottingham, UK
Mere Way
Ruddington, Nottingham
NG11 6JS
T: +44 115 974 9000
Quotient Sciences – US Headquarters – Philadelphia, PA
3080 McCann Farm Drive
Garnet Valley, PA 19060
T: (800) 769-3518
W: quotientsciences.com
Linkedin: https://www.linkedin.com/company/quotient-sciences
Twitter: https://twitter.com/Quotient_Sci
Facebook: https://www.facebook.com/quotientsciences
Instagram: https://www.instagram.com/quotient_sci
Youtube: https://www.youtube.com/@quotientsciences
Integrated drug development programs so molecules can become cures, fast
Quotient Sciences is a drug development and manufacturing accelerator providing integrated programs and tailored services across the entire development pathway. Cutting through silos across a range of drug development capabilities, we save precious time and money in getting drugs to patients.
We bring together integrated contract research, development, manufacturing and clinical testing services for small molecules and synthetic peptide drug programs. We’re a trusted partner to support:
Quotient Sciences Translational Pharmaceutics®: Our flagship platform for drug development
For over 15 years and over 1,000 molecules, our Translational Pharmaceutics® platform for drug development has helped global pharma and biotechs accelerate molecules to market. Our flagship platform for drug development is Translational Pharmaceutics®. This platform integrates capabilities for on-demand cGMP drug product development and manufacturing with clinical testing, all within a single organization and program of work. Trusted for over 16 years and with more than 500 programs completed, Translational Pharmaceutics® provides flexible CMC and clinical strategies, enables better decision making based on emerging human clinical data, streamlines vendor management, and ultimately, accelerates drug development timelines by up to 12 months or more.
Our expertise in understanding dependencies between drug substance properties, formulation design, and clinical outcomes enables us to enhance development efficiency. Having both drug substance and drug product manufacturing activities under one organization allows us to deliver integrated chemistry, manufacturing, and controls (CMC) development activities for both pre-clinical and clinical studies in parallel, simplifying the supply chain and improving the likelihood of downstream clinical and commercial success.
Tailored Services
FEATURED RESOURCES (Click on titles)
Info Sheet: Charles River and Quotient Sciences Collaboration
Whitepaper: Assessing the financial impact of Translational Pharmaceutics®
Whitepaper: Strategies to accelerate modified release formulations
Whitepaper: Accelerate the development of orphan drugs
Info Sheet: Drug substance capabilities
Posted Date: 12/1/2023
This record has been viewed 6200 times.